PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a finished-dose generic company from Türkiye

Selling into Europe as a finished-dose generic company from Türkiye

Move your Turkish generics onto European shelves without a stalled dossier.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Türkiye, Finished-dose generic companywho it is written for

Why this training matters

At day 120 of your Decentralised Procedure, the list of questions asks for evidence on your Turkish site that nobody on the team prepared. The clock stops while people hunt for it. The launch date moves, and the production line waits on stock with nowhere to go.

What changes after this course

Your team files the dossier, prepares the site and answers authorities the way European reviewers expect. Partners get clear answers on pricing, contracts and importation. You hold a certificate for each learner and a training record per person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory team files the Marketing Authorisation Application dossier in the Common Technical Document layout reviewers expect. Module 3 holds the quality data in the right place, Module 1 passes validation, and the day 120 list of questions in the Decentralised Procedure has fewer surprises. The clock stops less often, and your launch date holds.

Quality assurance walks your Turkish site the way a European inspector would, using EudraLex Volume 4 Part I and Annex 11 on computerised systems as the checklist. Gaps in batch records and data integrity get fixed before the visit is booked. The inspection report then has little to say that you did not already know.

The pharmacovigilance team builds its system before the first pack ships. Your Qualified Person for Pharmacovigilance has access to the safety database, the Pharmacovigilance System Master File is current, and serious adverse reaction reports reach EudraVigilance inside the 15 days the law sets. An inspector's first question has a document behind the answer.

Commercial directors price against national reimbursement rules and reference pricing before a distributor asks for a number. The distribution contract settles who holds the marketing authorisation, who carries Good Distribution Practice duties and what Regulation 2022/720 allows. At the border, the importer's Qualified Person has the batch file, and the packs carry the safety features Delegated Regulation 2016/161 requires.

Who needs this training

  • Regulatory Affairs Manager

    The Decentralised Procedure reaches day 120 and the list of questions lands on your desk. You answer from a file built to Common Technical Document rules, not from a scramble through old folders.

  • Quality Assurance Head

    A European inspector books a visit to your Turkish site. You have already walked the floor against EudraLex Volume 4, closed the batch record gaps and rehearsed the answers your team will give.

  • Business Development Director

    A European distributor sends a draft contract. You spot the clause on marketing authorisation ownership and the sole-distribution terms that Regulation 2022/720 limits, and you send back marked changes, not a request for more time.

  • Supply Chain Manager

    A pallet of finished-dose generics sits at the border while storage charges build up. You know which batch certificate, importation document and Falsified Medicines Directive safety features the customs officer and the importer need.

  • Pharmacovigilance Officer

    A serious adverse reaction report arrives on a Friday afternoon. You know the 15-day limit, who signs off and how the report reaches EudraVigilance, so the Qualified Person for Pharmacovigilance is never the bottleneck.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Finished-dose generic company

Countries: Türkiye

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Structure Module 3 and Module 1 of a Common Technical Document dossier so it clears European validation.
  2. Run a mock inspection of your Turkish site against EudraLex Volume 4 and list the gaps to close.
  3. Choose between the Centralised, Decentralised and Mutual Recognition Procedures for a given generic and defend the choice.
  4. Submit serious adverse reaction reports to EudraVigilance inside the legal time limit.
  5. Classify a post-approval change as Type IA, Type IB or Type II under Regulation 1234/2008.
  6. Check that your packs carry the safety features required by Delegated Regulation 2016/161.
  7. Mark up a distribution contract to settle marketing authorisation ownership and Good Distribution Practice duties.

What the company gets

  • Your Turkish site meets a European inspector with batch records, data integrity controls and a quality manual already checked against EudraLex Volume 4.
  • Your dossier is built to the Common Technical Document layout, so fewer questions arrive at day 120 and fewer clock stops push back the launch.
  • Distribution contracts state who owns the marketing authorisation and who carries each Good Distribution Practice duty, so a partner cannot walk away with your rights.
  • Shipments reach the importer's Qualified Person with the batch documents and safety features in place, so fewer pallets wait at customs.
  • Each learner receives a certificate, and you hold a training record per person, ready to show an auditor.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Size up the European Union generic market and pick your first countries

    • Why the largest European markets are not always the best first target for your dosage forms.
    • How to read a country's tender and substitution rules before you spend on a single dossier.
    • The market checks that tell you which country pays back your Turkish cost base first.
  2. 2Choose between the Centralised, Decentralised and Mutual Recognition routes

    • When the Decentralised Procedure fits your generic and when the Centralised Procedure is the better door.
    • How to choose the Reference Member State that suits your product and your timeline.
    • What to do when a concerned Member State asks for a section your Reference Member State did not.
  3. 3Pass a European Good Manufacturing Practice inspection at your Turkish site

    • How to run a mock inspection of your Turkish site before a European inspector books the visit.
    • The deficiencies in batch records and data integrity that turn a routine visit into a critical finding.
    • Why a quality manual built for Turkish inspectors can still fail a European one.
  4. 4Build a Marketing Authorisation Application dossier that clears review

    • How to lay out Module 3 of the Common Technical Document so reviewers find each answer fast.
    • The bioequivalence gaps in Module 5 that make assessors stop your application clock.
    • What validation checks in Module 1 before a single assessor reads your science.
  5. 5Set up Good Pharmacovigilance Practices before your first European sale

    • Why your Qualified Person for Pharmacovigilance must reach your safety database from day one.
    • How to meet the 15-day limit for serious adverse reaction reports in EudraVigilance.
    • How to keep your Pharmacovigilance System Master File ready for an inspector's first request.
  6. 6Match your pricing to European reimbursement models and reference pricing

    • How national pricing and reimbursement bodies decide whether your generic gets listed at all.
    • Why one low price in one country can follow your product into the next.
    • The legal time limits for national pricing decisions, so you know when to chase a late answer.
  7. 7Pitch your generics to European payers and prescribers in terms they accept

    • How to build a value story for a payer that rests on supply reliability, not only on price.
    • The advertising limits in Title VIII of Directive 2001/83 that keep your sales material lawful.
    • Why the pitch that wins in Türkiye loses a European tender, and what to change first.
  8. 8Clear European customs and importation checks with the batch file ready

    • How the Qualified Person at your European importer certifies each batch under Annex 16 before release.
    • The safety features Delegated Regulation 2016/161 puts on your packs, and who loads the data.
    • What to do when customs holds a pallet because the importation paperwork does not match the batch.
  9. 9Draft distribution contracts that keep your intellectual property yours

    • The clause that settles who owns the marketing authorisation and the dossier when the contract ends.
    • When a sole-distributor deal fits within Regulation 2022/720 and when it breaks competition law.
    • Why a handshake deal leaves Good Distribution Practice duties with nobody.
  10. 10File variations under Regulation 1234/2008 and renew without a gap

    • How to sort a change into Type IA, Type IB or Type II under Regulation 1234/2008 before you file.
    • When a change lets you keep shipping and when it makes you wait for approval.
    • The renewal filing date, set nine months before expiry, that keeps your authorisation alive.
  11. 11Reply to European authorities in time to keep your timeline

    • How to answer a request for supplementary information before the clock-stop period runs out.
    • What to say when an assessor challenges your bioequivalence data and you disagree.
    • How national business habits change the way a reply to an authority should be worded.
  12. 12Prevent recalls and market access delays across your European launch

    • How to write a contingency plan for the day a market access roadblock hits your launch.
    • The operational weak points that quietly turn a supply failure into a recall.
    • What to do in the first hours of a supply chain failure to avoid a product recall.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Türkiye, Finished-dose generic company. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team